Viatris to Host Virtual Investor Event and Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) will host an investor event on February 28, 2022, at 8:30 a.m. ET, where the CEO, President, and CFO will present the company's fourth quarter and full year 2021 financial results. The event will provide insights into Viatris' two-phased strategic roadmap. Interested investors can access a live webcast at investor.viatris.com, with an archived version available afterward. Viatris focuses on delivering high-quality medicines globally, with over 1,400 approved molecules across various therapeutic areas.

Positive

• Upcoming investor event scheduled for February 28, 2022, to discuss FY 2021 financial results.
• Comprehensive product portfolio with over 1,400 approved molecules across multiple therapeutic areas.

Negative

• None.

PITTSBURGH, Feb. 4, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will host its investor event the morning of Monday, February 28, 2022, beginning at 8:30 a.m. ET.

During the event, Chief Executive Officer Michael Goettler, President Rajiv Malik and Chief Financial Officer Sanjeev Narula will share the company's financial results for the fourth quarter and full year 2021 and will provide additional detail on the company's two-phased strategic roadmap.

Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time. 

About Viatris  
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 38,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-host-virtual-investor-event-and-report-fourth-quarter-and-full-year-2021-financial-results-on-february-28-2022-301475342.html

SOURCE Viatris Inc.

FAQ

When is Viatris' investor event scheduled for 2022?

Viatris' investor event is scheduled for February 28, 2022, at 8:30 a.m. ET.

What will Viatris discuss during the investor event?

Viatris will discuss its fourth quarter and full year 2021 financial results and its two-phased strategic roadmap.

How can I access Viatris' investor event?

You can access the live webcast of the investor event at investor.viatris.com.

What is the significance of the February 28, 2022 event for Viatris?

The event is significant as it will provide detailed financial results and strategic insights for Viatris, impacting investor expectations.